Loading clinical trials...
Loading clinical trials...
The purpose of this study is to examine how different messages about risk of melanoma can impact the way people protect themselves against developing these diseases.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
NCT06532279 · Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, and more
NCT07088211 · Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT05639972 · HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, and more
NCT05076760 · Solid Tumor, Advanced Cancer, and more
NCT07276399 · Squamous Cell Carcinoma of Head and Neck
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida
Ponce School of Medicine
Ponce
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions